Cytocom, Inc.

Feb 16, 2021

Cytocom Updates Investigational New Drug Application for Phase 2 Clinical Trial of CYTO-205 for the Treatment of COVID-19

Dec 22, 2020

Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During "J.P. Morgan Week 2021"

Nov 10, 2020

Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer

Oct 27, 2020

Cytocom Strategic Vision Conference Call Reminder

Aug 20, 2020

Cytocom, Inc. Announces Agreement to Reacquire Rights to Lead Drug Candidate CYTO-201 and CYTO-401 in Emerging Markets

Jul 20, 2020

Cytocom Announces Acquisition of ImQuest Life Sciences